Glucocorticoid treatment determines higher non-HDL cholesterol, hypertriglyceridemia and glucose intolerance, and confers a diminished effect of CETP-629C > A promoter polymorphism on HDL cholesterol in growth hormone-replaced hypopituitary subjects